Lowering Drug Pricing and Reducing OOP Cost

Together with 52  patient advocacy groups, we submitted a response to the U.S. Department of Health & Human Services (HHS) RFI on its Blueprint to Lower Drug Prices & Reduce OOP Costs on July 16, 2018. Our patients are our priority, and we want to be sure their needs are considered in future policy development.

Read our full letter to the Department of Health and Human Services online.

Recognizing Black Maternal Health Week

While the United States has one of the highest maternal mortality rates among developed countries,…

Read More

Diverse Women Leaders Making History for Heart Health

Not only were a record 127 women sworn in as members of Congress in January,…

Read More

ACA is Nine Years Old and Still Top of Mind for Lawmakers

Amy’s Advocacy Corner   On March 23, 2019, the Affordable Care Act (ACA) celebrated its…

Read More